MBJ: FDA, Pfizer, Merck join WHO in Memphis for global drug conference
Pharmaceutical industry representatives and regulators from 13 countries were in Memphis this week to discuss safety strategies for global pharmaceutical manufacturing, shipping and delivery.
University of Tennessee Health Science Center (UTHSC) hosted 75 attendees from June 26-29. Agencies represented included the World Health Organization, the U.S. Public Health Service, and the Food and Drug Administration (FDA), Merck and Co. Inc.; Pfizer; and Johnson & Johnson, and attendees came from countries including Indonesia, the Philippines, Peru, Mexico, Japan, Russia, Thailand and Switzerland.
UTHSC will open its new $16 million Plough Center for Sterile Drug Delivery Systems pharmaceutical manufacturing facility late this summer.
Ken Brown, executive executive vice chancellor and chief operations officer for UTHSC, has been active in global pharmaceutical supply chain efforts, making presentations in China, the Philippines and Peru and hosting delegates at UTHSC from China and Africa.
“The impact of UTHSC hosting this kind of event is that, for the first time, a public U.S. university has held a conference supporting the international efforts of the Asia Pacific Economic Cooperation, an organization of 21 Pacific Rim member economies, in its efforts to ensure the safety of individuals living within those economies from substandard, spurious, falsely labelled, falsified and/or counterfeit medicines,” Brown said.
Conference topics included product security tools, tracking to mitigate supply chain vulnerabilities, risk factors and best practices to prevent product diversion and systems and processes to detect falsified medicines.
Bernstein and Brian Johnson, senior director of Pfizer Supply Chain Security for Pfizer Global Supply, co-chaired the conference.